Advanced search
Publication Cover
Renal Failure Volume 32, 2010 - Issue 3
Submit an article Journal homepage
900
Views
5
CrossRef citations to date
0
Altmetric
Clinical Studies

Long-term follow-up of co-administration of diltiazem and cyclosporine in Chinese kidney transplant recipients

Wujun Xue Kidney Transplantation Center, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, ChinaCorrespondence[email protected]
,
Xiaoming Ding Kidney Transplantation Center, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China
,
Puxun Tian Kidney Transplantation Center, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China
,
Xiaoming Pan Kidney Transplantation Center, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China
,
Hang Yan Kidney Transplantation Center, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China
,
Jun Hou Kidney Transplantation Center, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China
,
Xinshun Feng Kidney Transplantation Center, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China
,
Heli Xiang Kidney Transplantation Center, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China
&
Xiaohui Tian Kidney Transplantation Center, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China
 show all
Pages 314-319 | Received 29 Aug 2009, Accepted 13 Dec 2009, Published online: 06 Apr 2010

REFERENCES

  • Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342(9):605.
  • Weir MR. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression. Am J Med. 1991;90(5A):32S.
  • Kahan BD. Cyclosporine. N Engl J Med. 1989;321(25):1725.
  • Chrysostomou A, Walker RG, Russ GR, d'Apice AJ, Kincaid-Smith P, Mathew TH. Diltiazem in renal allograft recipients receiving cyclosporine. Transplantation. 1993;55(2):300.
  • Patton PR, Brunson ME, Pfaff WW, A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome. Transplantation. 1994;57(6):889.
  • Ingsathit A, Sumethkul V, Chalermsanyakorn P, Jirasiritham S. Co-administration of diltiazem and cyclosporine for kidney transplant recipients: A four year follow-up study. J Med Assoc Thai. 2006;89(Suppl. 2):S235.
  • Wagner K, Albrecht S, Neumayer HH. Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: A prospective randomized study. Am J Nephrol. 1987;7(4):287.
  • Martin JE, Daoud AJ, Schroeder TJ, First MR. The clinical and economic potential of cyclosporin drug interactions. Pharmacoeconomics. 1999;15(4):317.
  • Jones TE. Survey of cyclosporin-sparing agent use in Australasian transplant centres. Aust N Z J Med. 1996;26(6):772.
  • Racusen LC, Solez K, Colvin RB, The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55(2):713.
  • Grino JM, Sabate I, Castelao AM, Alsina J. Influence of diltiazem on cyclosporin clearance. Lancet. 1986;1(8494):1387.
  • Bleck JS, Thiesemann C, Kliem V, Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients. Br J Clin Pharmacol. 1996;41(6):551.
  • Halloran P, Mathew T, Tomlanovich S. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation. 1997;63(1):39.
  • Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation. 1995;60(3):225.
  • Pascual M, Theruvath T, Kawai T. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002;346(8):580.
  • Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RDM. Calnineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation. 2004;78(4):557.
  • Li Y, Xue WJ, Tian PX, Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation. Transplant Proc. 2009;41(5):1565.
  • McCauley J, Ptachcinski RJ, Shapiro R. The cyclosporine-sparing effects of diltiazem in renal transplantation. Transplant Proc. 1989;21(6):3955.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.